Drug Approval | December 31, 2022
Zydus receives final approval from USFDA for Triazolam Tablets
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Cipla and Ethris partner for the development of mRNA-based therapies
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The new facility will be able to handle four times as many patients as the previous facility.
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
Subscribe To Our Newsletter & Stay Updated
